Released Aug 8, 2017, after the close
10-Q filed Aug 8, 2017, 39 days after period end · 0001162194-17-000091
Q2 2017 · 10-Q
Revenue$23.91M$23.91M −15.1% vs Q2 2016−6.3% vs Q1 2017
Net Income-$16.93M-$16.93M N/M vs Q2 2016N/M vs Q1 2017
EPS Diluted-$0.58-$0.58 N/M vs Q2 2016N/M vs Q1 2017
Operating Income-$16,487,000N/M
Operating Cash Flowderived-$8,290,000N/M
Free Cash Flowderived-$8,432,000N/M
Margins · derived
Operating margin-68.9%−4.5 pt vs Q2 2016
Net margin-70.8%−4.7 pt vs Q2 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $23.91M | $28.17M | $28.62M | $27.61M |
| Net Income | -$16.93M | -$18.62M | -$15.24M | -$12.68M |
| EPS Diluted | -$0.58 | -$0.64 | -$0.53 | -$0.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR